Many Bright Ideas Technologies Inc. is a Canadian life science company specializing in the development and commercialization of genomic-based technologies. Its main focus has been on creating prognostic genomic tests, particularly for non-small-cell lung cancer, aiming to advance precision medicine in oncology. The company operates within the biotechnology and pharmaceutical sectors, offering microarrays and gene analysis services that support pharmaceutical, biotech, and research institutions. Headquartered in Vancouver, it plays a role in bringing innovative genomic diagnostic tools to various industrial applications, seeking to impact healthcare through genomic science and technology commercialization.